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Background: P2X7 receptors are important in inflammation and immunity, but excessive activation results in cell death.
Results: Facilitation of P2X7 receptor currents and dilation of the pore are enhanced by cholesterol depletion and reduced by
cholesterol loading.
Conclusion: Plasma membrane cholesterol destabilizes the open and dilated states of the receptor pore.
Significance: Targeting of P2X7 to cholesterol-rich lipid rafts may protect cells from death.
P2X7 receptors are nonselective cation channels gated by
high extracellular ATP, but with sustained activation, receptor
sensitization occurs, whereby the intrinsic pore dilates, making
the cell permeable to large organic cations, which eventually
leads to cell death. P2X7 receptors associate with cholesterol-
rich lipid rafts, but it is unclear how this affects the properties of
the receptor channel. Here we show that pore-forming proper-
ties of human and rodent P2X7 receptors are sensitive to pertur-
bations of cholesterol levels. Acute depletion of cholesterol
with 5 mM methyl--cyclodextrin (MCD) caused a substantial
increase in the rate of agonist-evoked pore formation, as mea-
sured by the uptake of ethidium dye, whereas cholesterol load-
ing inhibited this process. Patch clamp analysis of P2X7
receptor currents carried by Na and N-methyl-D-glucamine
(NMDG) showed enhanced activation and current facilitation
following cholesterol depletion. This contrasts with the inhibi-
tory effect of methyl--cyclodextrin reported for other P2X
subtypes. Mutational analysis suggests the involvement of an
N-terminal region and a proximal C-terminal region that com-
prises multiple cholesterol recognition amino acid consensus
(CRAC) motifs, in the cholesterol sensitivity of channel gating.
These results reveal cholesterol as a negative regulator of P2X7
receptor pore formation, protecting cells from P2X7-mediated
cell death.
P2X7 receptors are ATP-gated cation channels, highly
expressed in cells of hematopoietic lineage, which play an
important role in inflammation and immunity (1–3). Inmacro-
phages, the P2X7 receptor can trigger inflammasome activation
and IL-1 secretion, production of reactive oxygen species, and
killing of intracellular microorganisms (4, 5). The receptor is
also found in endothelial and epithelial cells, where it regulates
ion transport, secretion, cell survival, and apoptosis (6–9).
P2X7 is up-regulated in many other tissues under pathological
and pro-inflammatory conditions and can trigger cell death
(10). These diverse and potentially severe outcomes of P2X7
activation mean that regulation of the receptor is crucial.
P2X7 is the low affinity P2X receptor that responds to patho-
logically high levels of extracellular ATP, thus mediating the
effects of ATP as a danger signal (10, 11). It can, however, be
partially ligated and activated by much lower levels of ATP,
thereby contributing to normal physiological responses. Its
ability to respond to a wide range of ATP concentrations can be
explained by ATP binding to the three sites on the trimeric
receptor with negative cooperativity (12). Partial occupancy
results in opening of an intrinsic pore nonselective for small
mono- and divalent cations including Ca2, whereas full occu-
pancy at highATP concentrations will, with some delay, trigger
the dilation of the pore to accommodate much larger organic
cations. Once in this sensitized or facilitated state, the process
reverses slowly and the receptor pore dilatesmore rapidly upon
subsequent application of agonist, eventually leading to cell
death. Thus, the rate and extent of P2X7 sensitization deter-
mine the outcome of receptor activation. Themechanisms that
regulate P2X7 receptor sensitization are not well characterized,
although species differences have been described; the human
P2X7 receptor sensitizes considerably more slowly in response
to repeated or prolonged agonist application than the rat and
mouse forms, and although Ca2/calmodulin binds to the rat
receptor to promote sensitization, it does not regulate the
human receptor (13, 14).
Like many other ionotropic receptors, the ATP-gated P2X
receptors associate with lipid rafts, as shown by their low buoy-
ant density in a sucrose density gradient following cell fraction-
ation (15–20). These membrane microdomains, rich in choles-
terol and sphingolipids, attract some proteins but exclude
others, thus providing a platform for the organization of dis-
tinctive signaling complexes (21, 22). The targeting of P2X7 to
rafts has been demonstrated for endogenous receptors in sali-
vary gland cells and airway epithelial cells, as well as for heter-
ologously expressed receptors in HEK 293 cells (17, 18, 23–26).
Palmitoylation of cysteines within the distinctively long cyto-
plasmic C terminus of P2X7 is suggested to promote raft asso-
ciation (18), although it is unclear which of the 17 conserved
cysteines within this region have this covalent modification. In
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airway epithelial cells, P2X7 is reported to form a complex with
caveolin-1, a key component of specialized invaginated lipid
rafts called caveolae (23, 24). Perturbation of lipid rafts may
disrupt the assembly of signaling complexes, but it can also
directly affect the activity of proteinswithin these domains (27).
Cholesterol has been shown to play a critical role in regulating
the activity of many integral membrane proteins including ion
channels (28). For the P2X7 receptor, perturbation of lipid rafts
has been shown to affect downstream signaling pathways, in
particular those associated with changes in lipid metabolism
(16), but the direct effect on channel activation and sensitiza-
tion is unknown.
The role of lipid rafts in the regulation of P2X7 receptor
function is of interest for several reasons. First, some cells that
express P2X7 receptors, such as macrophages and lympho-
cytes, have poorly defined or absent caveolae, whereas others,
such as epithelia, are highly enriched in caveolae, so it seems
likely that the lipid environment of P2X7 receptors will differ in
a cell type-dependent manner (27). Second, activation of P2X7
receptors increases ceramide production (16, 29, 30), which has
the potential to remodel rafts and might contribute to activity-
dependent regulation of P2X7 receptor activation. Third, per-
turbation of lipid rafts and changes in plasma membrane cho-
lesterol are associated with inflammation (31), so given the key
role of P2X7 in mediating pro-inflammatory actions of extra-
cellular ATP, it is important to understand how these changes
may affect P2X7 function in the innate immune response and in
chronic inflammatory diseases.
Changes in P2X receptor function after acute perturbation of
lipid rafts has been shown for P2X1, P2X3, and P2X4 receptors;
cholesterol depletion with methyl--cyclodextrin (MCD)4
inhibits channel activation (15, 19, 32, 33). Interestingly,
the inhibition of P2X1 receptor currentswas prevented by prior
incubation with a cytoskeletal stabilizing agent, jasplakinolide,
implicating cytoskeletal changes in this inhibition (34). P2X2
receptor currents are insensitive toMCD-mediated cholesterol
depletion, and this differential sensitivity of P2X1 and P2X2
receptorswas attributed to a regionwithin theN terminus close
to the first transmembrane domain (15). In this study, we com-
pared the effects of cholesterol depletion and cholesterol load-
ing on human and mouse P2X7 receptor whole-cell currents
and large pore formation. Unlike other P2X receptor subtypes,
acute depletion of cholesterol enhanced agonist-evoked cur-
rents and membrane permeabilization, whereas cholesterol
loading suppressed P2X7 receptor function. N- and C-terminal
regions proximal to the transmembrane domains are involved
in the cholesterol dependence of channel gating. Thus, choles-
terol acts as a negative regulator of P2X7 receptor channel acti-
vation and sensitization to prevent excessive activation.
EXPERIMENTAL PROCEDURES
Reagents and Drugs—All reagents were purchased from Sig-
ma-Aldrich unless otherwise stated. Drugs were made up in
DMEM (Life Technologies), and cells were pretreated at 37 °C,
5% CO2 in a humidified incubator. MCD and -cyclodextrin
(CD) were used at 5 mM for 15min, and water-soluble choles-
terol was used at 100 g/ml for 30 min. Pan-caspase inhibitor,
zVAD-FMK, was purchased fromBioVision Inc. (Milpitas, CA)
and used at 5M for 1 h. Latrunculin-A was used at 5M for 30
min. Jasplakinolide was used at 30 nM for 1 h, and ()-blebbi-
statin was used at 100M for 1 h; bothwere purchased from the
Cayman Chemical Company (Ann Arbor, MI). For bromo-
palmitate (BrP), a stock solution of 100 mM was made up fresh
inDMSOeach time and diluted 1:1000 inDMEMplus serum to
give a final concentration of 100M for 16 h. For carbenoxolone
treatment, cells were not pretreated, but 30 M was present in
all solutions used in the experiment. Rabbit polyclonal P2X7 C
terminus antibody was obtained from Alomone Labs (Jerusa-
lem, Israel), and anti-mouse and anti-rabbit HRP-conjugated
secondary antibodies were from Thermo Fisher Scientific and
Bio-Rad, respectively.
Cell Culture—HEK 293 cells and TSA 201 cells were main-
tained in DMEM supplemented with 10% fetal bovine serum,
100 units/ml penicillin, and 50 units/ml streptomycin and
transfected using Lipofectamine 2000 (Life Technologies) and
calcium phosphate, respectively, as described previously (35).
Bone marrow-derived macrophages were isolated from the
femora of 5–6-week-old mice and cultured as described previ-
ously (36).
Dye Uptake—Transfected TSA 201 cells on glass coverslips
were bathed in reduced divalent normal extracellular solution
(RD NES; 149 mM NaCl, 0.8 mM KCl, 0.6 mM CaCl2, 0.08 mM
MgCl2, 10 mM D-glucose, 10 mM HEPES, pH 7.3) and imaged
using the 40 oil immersion objective on a confocal micro-
scope at room temperature. Ethidium bromide (20 M in RD
NES) and BzATP (300 M in RD NES, but 30 M for mouse
P2X7k) were added at the specified time points, and change in
fluorescence was recorded using LSM510 software (Zeiss, Ger-
many). Ethidium bromide was excited at 543 nm, and emission
light was collected at wavelengths 560 nm. Using ImageJ
(Wayne Rasband, National Institutes of Health), the fluores-
cence intensity of each transfected cell (enhanced GFP was co-
transfected as a marker) was recorded as a function of time and
the average per coverslipwas calculated, and the average uptake
in five untransfected cells on the same coverslip (which was
consistently low) was subtracted from the average of each cov-
erslip to remove any drug effects that were not due to P2X7
activation. The rate of uptake was determined between 10 and
50 s after agonist application.
Cholesterol Assay—Cholesterol and protein levels were
measured using the Amplex Red cholesterol assay kit (Life
Technologies) and Pierce BCA protein assay kit (Thermo
Fisher Scientific), respectively.
Electrophysiology—Standardwhole-cell recordings were per-
formed at room temperature using anAxopatch 200B amplifier
(Molecular Devices, Sunnyvale, CA). Patch pipettes (5–10
megaohms) were pulled from borosilicate glass (1B150F-4;
4 The abbreviations used are: MCD, methyl--cyclodextrin; CD, -cyclodex-
trin; BrP, bromopalmitate; NES, normal extracellular solution; RD NES,
reduced divalent normal extracellular solution; NMDG, N-methyl-D-glu-
camine; TMD, transmembrane domain; CRAC, cholesterol recognition
amino acid consensus; BzATP, 3-O-(4-benzoyl)-benzoyl adenosine
5-triphosphate; DMSO, dimethyl sulfoxide; aa, amino acids; z, benzyl-
oxycarbonyl; fmk, fluoromethylketone; pF, picofarads.
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World Precision Instruments, Sarasota, FL). Whole-cell cur-
rents were low pass-filtered at 1 kHz. Picospritzer II (Parker,
Pine Brook, NJ) was used to apply 300 M BzATP made up in
extracellular solution with 0.05% (w/v) fast green to visually
ensure drug delivery. Transfected HEK 293 cells were voltage-
clamped at 60 mV. The pipette solution was 10 mM KCl, 70
mMK2SO4, 1mMMgCl2, 10mMHEPES, 75mM sucrose, pH 7.3.
Cells were maintained in NES (140 mM NaCl, 5 mM KCl, 2 mM
CaCl2, 1 mM MgCl2, 10 mM D-glucose, 10 mM HEPES, pH 7.3),
and 300 M BzATP in NES was applied for a duration of
5 s followed by 1-min washout. For N-methyl-D-glucamine
(NMDG) experiments, the pipette solutionwas 145mMNaCl,
10 mM EGTA, 10 mM HEPES, pH 7.35, and cells were main-
tained in NMDG buffer (155 mM NMDG, 2 mM CaCl2, 10 mM
glucose, 10 mM HEPES, pH 7.35).
Biotinylation of Surface Receptors—Transfected TSA 201
cells were rinsed twice with ice-cold PBS and then incubated
with 0.2 mg/ml EZ-Link sulfo-NHS-LC-biotin (Thermo Fisher
Scientific), freshly prepared in NES, for 1 h at 4 °C. Nonreactive
biotin was quenched, and unbound biotin was removed by
washing three timeswith stock buffer (25mMTris-HCl, 150mM
NaCl, 10 mM EDTA, pH 7.5). Cells were lysed in solubilization
buffer (stock buffer, 1% Triton X-100, 1 mM PMSF, protease
inhibitor cocktail (Roche Applied Science)) on a rotating wheel
for 1 h at 4 °C and then centrifuged at 18,000  g. A 50-l
aliquot of the supernatant was diluted in Laemmli sample
buffer and stored as the “total” protein sample, whereas the
remaining supernatant was added to 30 l of washed Pierce
Streptavidin UltraLink resin (Thermo Fisher Scientific) and
incubated on a rotating wheel at 4 °C for 2 h. Resin was centri-
fuged at 10,000 g and washed in stock buffer with 1% Triton
four times, and then proteins bound to the resin were eluted by
the addition of 50l of Laemmli sample buffer and stored as the
“biotinylated” protein sample. Samples were then analyzed by
SDS-PAGE and immunoblotting. Two wells of a 6-well plate of
confluent cells were solubilized in 350 l of solubilization
buffer unless otherwise stated.
DNAConstructs—Mouse P2X7 bearing an extracellular FLAG
tag (DYKDDDDK)betweenHis85 andSer86wasgeneratedby two-
stagePCRusing the followingpairsof senseandantisenseprimers:
first, 5-AGCATAAAGCTTGTCGCCACCATGCCGGCTTG-
CTGCAGCTGG-3 and 3-TTTGTCGTCGTCGTCTTTATA-
GTCGTGTCCTAACTTCGTCACCCCACC-5, and second, 5-
GACTATAAAGACGACGACGACAAAAGCATCTTTGACA-
CTGCAGACTAC-3 and 3-GCTATAGCGGCCGCTCAGT-
AGGGATACTTGAAGCC-5. Thiswas subcloned into theClon-
tech GFP-N1 vector, using the NotI site to excise the coding
sequence for GFP.
The human P2X7 18 amino acid mutant was generated
by two-stage PCR using the following pairs of sense and anti-
sense primers: first, 5-AGGATAAAGCTTGTCGCCACC-
ATGCCGGCCTGCTGCAGCTGC-3 and 5-GTAGTATT-
CGTTGTTACTGGAGTAAGTGTC-3, and second, 5-T-
ACTCCAGTAACAACGAATACTACTACAGG-3 and 5-
GCATTACTCGAGTCAGTAAGGACTCTTGAAGCC-3.
This was subcloned into the Life Technologies pcDNA3.1
vector, using the HindIII and XhoI sites.
Single amino acid changes weremade using theQuikChange
II site-directed mutagenesis kit (Stratagene, La Jolla, CA). The
sequences of all amplified regions were verified using auto-
matedDNA sequencing (Source BioScience, Nottingham, UK).
Immunostaining—Live labeling of P2X7-FLAG was carried
out in HeLa cells, using a similar protocol to that described
previously (37, 38). 48 h after transfecting HeLa cells with the
P2X7-FLAG receptor and enhanced GFP (as a marker of trans-
fection), control cells and those preincubated with BrP (16 h),
MCD, or CD (5 mM for 15 min) were incubated with anti-
FLAG antibody for 1 h in NES at 12 °C, washed five times, and
fixed with 4% paraformaldehyde. Cells were then incubated in
blocking buffer for 1 h and then incubated with anti-mouse
Cy3-conjugated secondary antibody for 2 h at room tempera-
ture. Fluorescence was imaged using a Zeiss Axiovert LSM510
confocal microscope with 63 objective. Identical acquisition
parameters were used for image capture of individual experi-
ments. Images were imported into ImageJ, transfected cells
were outlined, and total pixel values were obtained. Experi-
ments were repeated three times, and at least 40 cells analyzed
each time.
Data Analysis—Line and bar graphs were generated using
Microsoft Excel. Error bars represent the S.E. The unpaired
Student’s t test was used to test for significance, unless other-
wise stated. The dose-response curve was generated using a
nonlinear regression curve fit equation in GraphPad Prism 6.
Prism was also used to generate scatter graphs and to perform
the two-way analysis of variance test.
RESULTS
Acute Manipulation of PlasmaMembrane Cholesterol Regu-
lates P2X7 Receptor Large Pore Formation—P2X7 receptor
pore formation was assayed by the uptake of ethidium produc-
ing an increase in fluorescence asmeasured by confocalmicros-
copy (Fig. 1A). For these experiments, mouse and human iso-
forms of P2X7 were expressed in TSA 201 cells, which are
modified HEK 293 cells that express the receptors to a higher
level. This improved the reliability of measuring dye uptake
mediated by the human receptor. Receptors were activated by
the application of the agonist BzATP in a reduced divalent
extracellular solution. A concentration that produces a maxi-
mal rate of dye uptake at both receptors (300 M) triggered a
much slower rate of ethidium uptake for the human as com-
pared with the mouse isoform consistent with a slower rate of
pore dilation (Fig. 1B). To examine the effects of acute deple-
tion of plasma membrane cholesterol, the cells were incubated
with 5 or 15 mM MCD for 15 min prior to recording. An
increase in cholesterol was achieved by 30min of preincubation
with 100 g/ml cholesterol, made water-soluble by loading in
MCD, and as control we used the analog CD, which does not
forma complexwith cholesterol. Verification that thesemanip-
ulations produced the expected changes in cholesterol content
of cells was achieved using the Amplex red cholesterol assay
(Fig. 1C). The decrease in cholesterol produced by a 15-min
incubation with MCD was small but significant and might be
limited by the relatively short duration of incubation as com-
pared with other studies (15, 39). The CD analog produced no
change, as expected, whereas cholesterol-loaded MCD pro-
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duced a significant increase in cholesterol. Following MCD
treatment, the BzATP-evoked rate of rise in ethidium fluores-
cence increased by 5.0-fold for human P2X7 and 2.2-fold for
mouse P2X7, whereas incubation with cholesterol-loaded
MCD produced a profound inhibition and CD had no effect
(Fig. 1, D–F). Over a range of BzATP concentrations, MCD
produced a large increase in the maximal rate of dye uptake
with a small leftward shift in the EC50 value (52 M with MCD
versus 74 M for control, for mouse P2X7) (Fig. 1G). Acute
manipulations of cholesterol produced similar effects on the
more active P2X7k mouse splice variant and on the rat P2X7
receptor (Fig. 1, H and I). Responses mediated by endogenous
P2X7 receptors in mouse bone marrow-derived macrophages
were also potentiated and inhibited by cholesterol depletion
and loading, respectively (Fig. 1J). Thus, although other P2X
receptors are inhibited by MCD treatment, the function of
P2X7 receptors is enhanced.
Membrane permeabilization to cationic dyes, triggered by
P2X7 receptor activation, has been reported to involve uptake
via pannexin hemi-channels and to be regulated by non-muscle
myosins (40, 41). To test whether pannexin-1 contributed to
ethidium uptake following cholesterol depletion, cells were
treated with a pannexin-1 inhibitor, carbenoxolone (30 M),
but this had no effect (Fig. 2A). We also tested the caspase
inhibitor, zVAD-FMK, as caspase-dependent cleavage of the C
terminus of pannexin-1 activates the pannexin pore (42), and
saw no change in BzATP-evoked ethidium uptake after MCD
treatment (Fig. 2A). The involvement of non-muscle myosin 2
was examined by treating cells with blebbistatin, a selective
inhibitor of its ATPase activity, but BzATP-evoked ethidium
FIGURE 1. P2X7 receptor-mediated dye uptake is enhanced by depletion of plasmamembrane cholesterol and reduced by loading of cholesterol. A,
example confocal images capturedduring 245-s time series tomeasure dye uptake. Timeof image capture, in seconds, is shown. Ethidiumbromidewas added
at 20 s, and 300M BzATP was added at 45 s. The increase in fluorescence as a result of ethidium uptake (red) into P2X7-expressing cells (green) is apparent. B,
human P2X7-mediated dye uptakewas slower thanmouse P2X7-mediated dye uptake (n 3 coverslips,10–30 cells per coverslip, p	 0.001), normalized to
human P2X7. C, measurements of cholesterol (chol) in TSA 201 cells. A 15-min preincubation with 5 or 15 mM MCD reduced cholesterol, 5 mM CD for 15 min
had no effect, and 100 g/ml water soluble cholesterol for 30 min increased cholesterol2-fold (n 3, *, p	 0.01, **, p	 0.001; ns, not significant). D, time
course of humanP2X7-mediated dye uptake, normalized to control. Uptakewas enhancedby 5mMMCDand inhibited by 100g/ml cholesterol (n 3–4, p	
0.05). E, 5 mM CD has no effect on human P2X7-mediated dye uptake, normalized to the untreated condition (n 3, p
 0.05). F, rate of P2X7-mediated dye
uptake 10–50 s after agonist application, normalized to control. Human P2X7 dye uptake was increased5-fold by 5 mM MCD and almost abolished by 100
g/ml cholesterol (n 66 alone, n 64 MCD and n 6 cholesterol, **, p	 0.001). Mouse P2X7 dye uptake was increased2.2-fold by MCD and reduced by
cholesterol (n 88 alone, n 50MCD and n 4 cholesterol, **, p	 0.001).G, concentration-response curves formouse P2X7 receptor-mediated dye uptake,
with and without pretreatment with 5 mM MCD. Responses were normalized to the rate of increase in fluorescence in untreated cells stimulated with 300 M
BzATP. H, time course of dye uptake mediated by themore active mouse P2X7k variant, stimulated with 30M BzATP, normalized to the untreated condition
(n 3, p	 0.05 for MCD, p	 0.001 for cholesterol). I, rat P2X7 dye uptake was enhanced by 5 mM MCD, but not significantly (p 0.07), and inhibited by 100
g/ml cholesterol (n 3, p	 0.05), normalized to the untreated condition. J, inmouse bonemarrow-derivedmacrophages, dye uptake via endogenous P2X7
was potentiated by 5 mM MCD and reduced by 100 g/ml cholesterol (n  4, p 	 0.001 for MCD, p 	 0.01 for cholesterol), normalized to the untreated
condition.
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uptake was unaltered both with and without MCD treatment
(Fig. 2B). These results suggest that the P2X7 receptor itself is
the likely target of cholesterol regulation. The inhibition of
P2X1 receptor currents by MCD treatment is blocked by prior
treatment with the actin-stabilizing agent, jasplakinolide. Nei-
ther jasplakinolide (30–50 nM) nor latrunculin-A, an inhibitor
of F-actin polymerization, reduced the potentiating effects of
MCD on P2X7 receptor-mediated dye uptake (Fig. 2, C andD).
Thus, cytoskeletal changes are unlikely to be involved in the
enhanced permeabilizing action of P2X7 following cholesterol
depletion.
MCD-mediated Cholesterol Depletion Potentiates P2X7
Receptor Current Amplitude and Sensitization—Whole-cell
currents mediated by the mouse and human P2X7 receptors
differ in the degree and rate at which they sensitize in response
to exposure to agonist, with human P2X7 showing a more pro-
nounced and slower rate of sensitization (13). We tested the
effects of depleting or loading cholesterol on currents activated
by repetitive 5-s applications of 300 M BzATP at both recep-
tors. The mouse P2X7 receptor gave reproducible responses
that were strongly inhibited by pretreatment withMCD loaded
with cholesterol (Fig. 3, A and B). Treatment with MCD alone
dramatically enhanced the amplitude of the current evoked by
the first application of agonist and, although subsequent
responses were also of larger amplitude, they showed some
desensitization, unlike the untreated cells. For the human P2X7
receptor, preincubation withMCD also caused a large increase
in the amplitude of the initial currents (Fig. 3, C and D). Under
control conditions, recordings showed considerable variability
in the degree of run-up (Fig. 3E). Approximately 40% showed a
profound run-up after 
10 applications of BzATP; for this
group, themean increase was6.1-fold. FollowingMCD treat-
ment, initial currents were already a similar magnitude to that
seen after run-up of untreated cells, and only two recordings
subsequently showed a modest run-up. Thus, for both mouse
and human P2X7, the effect ofMCD is to sensitize the receptor
to the initial application of agonist.
To investigate whether depleting cholesterol promotes the
receptor opening to a pore-dilated state, as suggested by the
ethidium uptake experiments, NMDG was used as the extra-
cellular charge-carrying ion. Mouse P2X7 receptor currents
were activated by a 40-s BzATP application, with and without
prior exposure to MCD. At a negative holding potential (60
mV), we expected to see a small outward current followed by an
inward current, as others have reported for the rat receptor,
reflecting the delayed dilation of the pore to accommodate
NMDG (12). Instead, for the control cells, there was either no
current or a small and slowly activating inward current (Fig.
3F). Following MCD treatment, inward currents activated
more rapidly and were of much larger amplitude, consistent
with cholesterol depletion promoting a pore-dilated state of
P2X7 (Fig. 3, F–H). To determinewhether or not the increase in
the peak current amplitude reflects a higher expression of the
receptor at the plasma membrane, surface-exposed proteins
were analyzed by biotinylation followed byWestern blot. There
was no change in either the biotinylated or the total levels of
mouse and human P2X7 receptors following MCD treatment
(Fig. 3I). Therefore the effects are on receptor activity.
An N-terminal Region Proximal to TMD1 Contributes to the
Cholesterol Dependence of P2X7 Receptor-mediated Dye
Uptake—Regions of the P2X7 receptor involved in sensitivity to
cholesterol were probed by mutagenesis analysis of the human
variant as this showed the greatest potentiation of dye uptake by
MCD. Previously, the differential sensitivity of P2X1 and P2X2
FIGURE 2. The enhancement in P2X7 receptor-mediated dye uptake by
MCD treatment is independent of pannexin-1 and cytoskeletal changes.
A, neither carbenoxolone (carb; 30 M) nor pretreatment with the caspase
inhibitor zVAD-FMK (zVAD; 5 M for 1 h) reduced human P2X7-mediated
ethidiumuptake followingMCD treatment. (n6,p
0.05).B, preincubation
with ()-blebbistatin (bleb; 100M for 1h), an inhibitor of non-musclemyo-
sin 2, had no effect on the rate of mouse P2X7-mediated dye uptake, with or
without MCD pretreatment (n 12, p
 0.05). C, the actin-stabilizing agent
jasplakinolide (jasp; 30 nM for 1 h) had no effect on human P2X7-mediated
dye uptake with or without MCD treatment (n 4–8, p
 0.05). D, latruncu-
lin-A (lat; 5 M for 30 min), an inhibitor of F-actin polymerization, had no
effect on the initial rate ofmouse P2X7-mediated dye uptake, with orwithout
MCD treatment (n 3–6, p
 0.05).
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receptors to cholesterol depletion was attributed to a region
within the middle of the N terminus, shown underlined in the
alignment of the N-terminal regions (Fig. 4A) (15). Mutating
residues 20–23 in P2X1 to those present in P2X2 (RMVL to
KVIV) removed the inhibition of currents produced by MCD.
The KV residues are common between P2X2 and P2X7, and so
we tested the effect of the reversemutations (K17R andV18M).
This had no effect on the rate of ethidium uptake under control
conditions but abolished the potentiation by MCD treatment
(Fig. 4, B and C). Cholesterol-loaded MCD was, however, still
effective in blocking dye uptake by this mutant, indicating that
sensitivity to cholesterol was altered but not lost. This sensitiv-
ity was apparent for whole-cell currents, which showed a sig-
nificant increase in amplitude following MCD treatment (Fig.
4E), although the2-fold increase was less than half that seen
with the wild type receptor. Currents were also inhibited by
cholesterol loading (current density was 1.0 pA/pF and 2.5
pA/pF from two recordings). These results suggest that this
N-terminal region contributes to the cholesterol sensitivity of
the P2X7 receptor but that other residues or regions of the
receptor are also involved in this process.
Cholesterol Sensing within the P2X7 Receptor C Terminus—
The sensor for plasma membrane cholesterol will lie either
within one of the transmembrane segments or in a region that
dips into themembrane but does not necessarily traverse it. For
example, the cholesterol-sensing region of large conductance
calcium-activated potassium channel was recently shown to be
in the cytosolic C terminus after TMD7 (43). The motif
FIGURE3.Acute changes in cholesterol affect P2X7whole-cell current amplitude, sensitizationandNMDGpermeability.A, example traces ofwhole-cell
patch clamp recordings fromHEK293 cells expressing themouseP2X7 receptor andenhancedGFP, stimulatedwith repeated5-s applicationsof 300MBzATP
followed by a 1-min wash. chol, cholesterol. B, mean current densities after one or more applications of BzATP, in untreated cells or cells pretreated with 5mM
CD, 5mMMCD, or 100g/ml cholesterol (n3–18 cells, *,p	0.01, **,p	0.001;ns, not significant).pF, picofarads.C, example traces ofwhole-cell recordings
from cells expressing the human P2X7 receptor, stimulatedwith repeated 5-s applications of 300MBzATP followedby a 1-minwash.D, mean current density
upon first agonist application, with and without 5 mM MCD pretreatment (n  18 cells, **, p 	 0.001). E, -fold change in current density from first agonist
application to last application (
10), where each point represents one cell. The solid line showsmean -fold change, and the dotted line is at 1. F–H, mouse P2X7
receptor currents in theNMDGextracellular solution, stimulatedwith 300MBzATP for 40 s.Meanpeak current densities and the10–90% rise timeare shown
(n  7–9, *, p 	 0.01). I, TSA 201 cells expressing mouse P2X7 or human P2X7 receptors were untreated or treated with 5 mM MCD for 15 min and then
surface-labeled with sulfo-NHS-LC-biotin. For mouse P2X7, 3 wells of a 6-well plate of cells were then solubilized in 350l of solubilization buffer, whereas for
human P2X7, a T75 flask of cells was solubilized in 1 ml. The Western blot shows the total lysate (T) and surface-biotinylated sample (B) blotted for P2X7 and
-actin. MCD treatment did not affect the proportion of P2X7 receptors at the surface.
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(L/V)X1–5YX1–5(K/R) has been described as a cholesterol rec-
ognition amino acid consensus (CRAC) motif; it was first iden-
tified in amitochondrial membrane transporter protein known
as the peripheral-type benzodiazepine receptor and has since
been identified in other proteins (44–46). Several tyrosine res-
idues in the vicinity of the transmembrane domains of P2X7 lie
within such a motif, including one within the N terminus adja-
cent to the KV residues (Tyr13), a tyrosine at the extracellular
end of TMD1 (Tyr51), a tyrosine at the cytoplasmic end of
TMD2 (Tyr358), and then slightly farther downstream, a series
of three adjacent tyrosine residues (Tyr382, Tyr383, and Tyr384)
within overlappingmotifs (Fig. 5A). The Y13Fmutation had no
effect on the rate of dye uptake, whereas the Y51F mutation
abolished this response (Fig. 5B). Analysis of surface-biotiny-
lated proteins showed no expression of this mutant at the
plasma membrane and a reduction in total expression, consis-
tent with its lack of function (Fig. 5C). This tyrosine is con-
served in all P2X receptors, although only in P2X7 is the Tyr
followed by positively charged residues at the2 and3 posi-
tions, hence conforming to the CRAC motif. The equivalent
mutation in P2X4 (Y54F) is tolerated without loss of function,
and even less conservative substitutions (e.g. Y54A) inhibit
function but not plasma membrane expression (47). This sug-
gests that in the P2X7 receptor, interactions involving this tyro-
sine are different and critical for the structure of the receptor.
Within the C terminus of P2X7, the individual Y358F and
Y383F mutations had little effect on dye uptake, although the
-fold increase produced by MCD treatment was reduced as
compared with the wild type receptor (Fig. 5B). This -fold
increase was further reduced in the triple mutant (Y382F/
Y383F/Y384F), and when combined with Y358F, the potentia-
tion by MCD did not reach significance (p 
 0.05). There was
no disruption in plasma membrane expression of these
mutants; in fact surface expression appeared to be slightly
increased (Fig. 5C).Within this background, theY51Fmutation
again completely disrupted plasma membrane expression.
These results suggest a concerted role for the multiple CRAC
motifs within the proximal C terminus in contributing to the
cholesterol sensitivity of the receptor. For this region to be
directly sensing cholesterol, it would need to be intimately asso-
ciated with the membrane. The neighboring positively charged
residues (Arg386, Lys388, and Lys395) are reported to interact
with phosphatidylinositol 4,5-bisphosphate (48), and down-
stream of this is a cluster of hydrophobic residues that could
also be important for membrane interactions (Fig. 5A). The
L398Amutation was tolerated without loss of receptor expres-
sion but reduced the rate of dye uptake (Fig. 5,D and E). Reduc-
ing hydrophobicity by substituting alanines at the Val401,
Phe403, and Val404 positions did, however, inhibit the plasma
membrane expression and function of the receptor (Fig. 5D,E),
suggesting that hydrophobicity here is important for its correct
folding and trafficking.
Immediately upstream of the Tyr382–384 CRAC motifs is a
series of cysteine residues that are potential sites of palmitoyla-
tion (Fig. 5A). A reduction in palmitoylation and targeting to
rafts are expected to reduce the sensitivity of the receptor to
MCD treatment. To investigate the role of palmitoylation in
cholesterol sensitivity, we initially tested the effects of BrP, an
inhibitor of palmitate incorporation, on receptor function and
cholesterol sensitivity. Following a 16-h preincubation with
BrP, the rate of dye uptake decreased although itwas still poten-
tiated by MCD treatment (Fig. 6, A and B). There was also an
FIGURE 4. The N terminus is important for the sensitivity of P2X7 receptor activity to cholesterol depletion. A, amino acid sequence alignment of the
N-terminal region of human P2X1, P2X2, and P2X7 receptors, with conserved amino acids highlighted in gray, P2X1 aa20–23 and equivalent residues in P2X2
underlined, and theP2X7 residues Lys17 andVal18 in red.B, time courseof dyeuptakemediatedby theK17R/V18Mmutant andwild typeP2X7, alone, pretreated
withMCD and loadedwith cholesterol (chol), normalized to the untreatedWT P2X7. C, bar graph of the relative rate of dye uptake normalized to the untreated
WT P2X7. Dye uptake mediated by the K17R/V18Mmutant is not potentiated by MCD, but is inhibited by cholesterol loading (WT: n 14 alone, n 11 MCD,
n 3 cholesterol; mutants: n 12 alone, n 11MCD, n 3 cholesterol; *, p	 0.05, **, p	 0.001; ns, not significant).D, whole-cell patch clamp recordings of
human P2X7 K17R/V18M receptor 5mMMCD pretreatment, stimulated with repeated 5-s applications of 300M BzATP followed by a 1-min wash. E, mean
peak current density upon first application of BzATP. MCD pretreatment potentiates initial current density (n 10–17 cells, **, p	 0.001), but the extent of
potentiation is less than the wild type receptor (p	 0.05, two-way analysis of variance). pF, picofarads.
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60% drop in plasma membrane expression of the receptor
and a reduction in its overall expression, which would account
for the reduced dye uptake response (Fig. 6, C and D). These
effects of BrP are not readily interpretable and could also be
off-target. As an alternative approach, the effect of removing
these potential palmitoylation sites was tested by deleting the
juxtamembrane cysteine-rich region (18aa). In the rat P2X7
receptor, deletion of this region accelerates receptor sensitiza-
tion but has no effect on dye uptake (12, 49). Surprisingly, the
equivalent deletion in human P2X7 (362–379) inhibited dye
uptake and its potentiation by MCD (Fig. 7, A and B). Surface
biotinylation indicated that the 18aa mutant was still
expressed at the plasmamembrane at a similar level as the wild
type receptor (Fig. 7C). Currentsmediated by P2X718aawere
small with unusually slow kinetics of activation and “flickery“ in
nature, suggesting that the pore was rapidly oscillating between
an open and shut state (Fig. 7D). The currents ran down rather
than sensitized with repeated application of agonist, and MCD
treatment reduced rather than enhanced the amplitude of the
initial response to BzATP application (Fig. 7E). These results
indicate the importance of this juxtamembrane region for nor-
mal pore gating and in conferring cholesterol sensitivity to this
process. Individual cysteine to alanine mutations within this
region were also made in an attempt to identify a critical cys-
teine residue. The C371A mutation had no effect on ethidium
uptake, C373A and C377Amutations inhibited uptake without
abolishing sensitivity toMCD treatment, and the C363Amuta-
tion abolished uptakewith orwithoutMCD treatment (Fig. 7F).
All mutants were expressed at the cell surface, and the C363A
mutant carried an inward current that showed some sensitiza-
tion and was potentiated byMCD (Fig. 7,G–I). Our conclusion
is that the C363A mutation disrupts pore dilation and dye
uptake via a mechanism independent of cholesterol sensitivity.
We failed to identify a key role for any one cysteine in confer-
ring sensitivity to acute cholesterol depletion, but this is con-
sistent with the findings of Gonnord et al. (18), which suggest
that multiple cysteine residues within the P2X7 C terminus are
palmitoylated.
DISCUSSION
The P2X7 receptor is unusual for an ion channel in that it has
two phases of activation; it opens initially to a cation-conduct-
ing pore that allows small mono- and divalent cations to per-
meate, but in response to prolonged or repetitive application of
agonist, it undergoes a sensitization process, resulting in
increased current amplitudes and dilation of the pore with
potentially harmful consequences for the fate of the cell (12,
50). In this study, we identify plasmamembrane cholesterol as a
key regulator of human and rodent P2X7 receptor sensitization
and pore dilation. The effects of cholesterol depletion and cho-
lesterol loading on P2X7 receptor function indicate that cho-
lesterol acts to suppress opening of the channel pore, particu-
larly its large pore, and thus limits excessive activation. This
appears to be particularly relevant for the human P2X7 recep-
tor, which normally mediates a much slower rate of dye uptake
than the rat or mouse isoforms. Therefore P2X7 receptors
FIGURE5.Cholesterol-sensingwithin theproximalC terminusof theP2X7 receptor.A, aminoacid sequenceof thehumanP2X7N terminus andTMD1, and
the endof the TMD2andproximal C terminus. TheCRACmotifs areunderlined, with constituent residues inbold and central tyrosines in red.Arrows indicate the
amino acids reported to interactwith phosphatidylinositol 4,5-bisphosphate (48), and the cluster of hydrophobic residues downstreamof these is in bold/blue.
The 18-amino acid cysteine-rich region is highlighted in gray, and its cysteines are in bold/green. B, bar graph of the relative rates of dye uptake 5 mM MCD
for P2X7 Tyr to Phemutants normalized to the untreatedWTP2X7 (WT: alonen 16,MCDn 5;mutants:n 3–6; *,p	 0.01, **,p	 0.001;ns, not significant).
C, cells expressing P2X7 WT or P2X7 mutants were surface-labeled with sulfo-NHS-LC-biotin. The Western blot shows the total lysate (T) and surface-biotiny-
lated sample (B) blotted for P2X7 and-actin. The Y51Fmutation inhibited surface and total expression of the receptor.D, bar graph of the relative rates of dye
uptake 5mMMCD, for hydrophobic to alaninemutants normalized to the untreatedWT P2X7 (WT: n 9;mutants: n 3–6; *, p	 0.05, **, p	 0.001). E, cells
expressing P2X7 WT or P2X7 mutants were surface-labeled with sulfo-NHS-LC-biotin. The Western blot shows the total lysate (T) and surface-biotinylated
sample (B) blotted for P2X7 and -actin. Surface expression was inhibited by V401A, F403A, and V404A mutations.
PlasmaMembrane Cholesterol as a Regulator of P2X7 Receptor
31990 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 289•NUMBER 46•NOVEMBER 14, 2014
 at M
RC Lab of M
olecular Biology on A
pril 14, 2015
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
localized to cholesterol-rich lipid rafts are expected to exhibit a
more reluctant mode of gating, and so targeting of receptors to
rafts may be a means of limiting the extent of receptor activa-
tion as well as organizing downstream signaling. Disruption of
lipid rafts, which we achieved with MCD treatment, has been
shown to occur in chronic inflammation (31), and so P2X7
receptor function may be enhanced in these conditions, with
associated pore dilation and cell death potentially contributing
to the pathogenesis of chronic inflammatory diseases.
Our finding that MCD treatment potentiates P2X7 receptor
function contrasts with its inhibitory effects on other P2X
receptor subtypes including P2X1, P2X3, and P2X4 (15, 19, 32).
It is also not entirely consistent with a previous study on rat
submandibular gland cells, in which preincubation with MCD
reducedATP-stimulated phospholipase A2 activity, but did not
affect the rise in cytosolic calcium (16). The study concluded
that opening of the P2X7 channel pore is unaffected by disrupt-
ing rafts, but coupling between the P2X7 receptor and sphin-
gomyelinase and ceramide generation occur preferentially
within rafts. Our study provides amuchmore directmeasure of
the activation and dilation of the P2X7 receptor pore. It is likely
that calcium responses evoked by ATP in submandibular gland
cells are not solelymediated by the P2X7 receptor, which is why
they were unaffected by MCD treatment. Sphingomyelin and
sphingomyelinase are concentrated within rafts, and therefore
generation of ceramide is expected to occur preferentially
within thesemicrodomains (22, 27). Thus, perturbation of lipid
rafts could concomitantly enhance the efficacy of agonist-stim-
ulated pore opening and dilationwhile disrupting the efficiency
of coupling between the receptor and lipid metabolism
pathways.
Mutational analysis of the P2X7 receptor supports a role for
both N-terminal and C-terminal regions proximal to the trans-
membrane domains in the cholesterol sensitivity of channel
gating. The region within the N terminus is equivalent to that
shown to regulate the sensitivity of the P2X1 receptor to MCD
treatment (15). Previous studies also highlight this region as
playing an important role in the activation and sensitization of
the P2X7 receptor. For example, threonine at position 15, just
upstream of the mutated lysine 17 and valine 18, when substi-
tuted for either glutamate or lysine, promotes the pore-dilated
state of rat P2X7 as measured by NMDG permeability (12).
Within the proximalC terminus of P2X7 are fourCRACmotifs,
andmultiple Tyr to Phemutations within thesemotifs progres-
sively lead to a reduction in MCD sensitivity. In a recent study,
multiple CRAC motifs within the C terminus of the BK-type
potassium channel were shown to contribute to the cholesterol
sensitivity of channel activity (43). Although CRAC motifs are
common, and the presence of amotif does not necessarily imply
that a protein binds cholesterol (51), close proximity of the
motif to the plasma membrane may be an important determi-
nant. For example, the CRAC motif reported to regulate can-
nabinoid type 1 receptor cholesterol sensitivity is at the end of
TMD7, and in the HIV-1 gp41 protein, the CRACmotif, which
binds cholesterol, is found immediately adjacent to the mem-
brane-spanning domain (45, 46). There is also evidence that
sterols are mainly in the cytoplasmic leaflet of the bilayer, sug-
gesting that regions of proteins located at the membrane-cyto-
sol interface are well placed for sensing cholesterol (52). We
propose that the proximal C-terminal region of P2X7 is in con-
tact with and may dip back into the plasma membrane, via
palmitoyl groups and hydrophobic residues. Comparing this
region with the proximal C terminus of the other P2X receptor
subtypes, the 18-amino acid cysteine-rich region is unique to
P2X7, but there are similarities in the sequences downstreamof
this. Similar to P2X7, P2X4 has three adjacent tyrosines,
whereas P2X1 has two. These are located immediately down-
stream of TMD2, and in both receptors are preceded and fol-
lowed by clusters of basic residues that are involved in binding
membrane phosphoinositides (53). In P2X1, these two
tyrosines lie within a sequence that conforms to two overlap-
ping CRAC motifs (Leu357-X4-Tyr362-Tyr363-X2-Lys366-
FIGURE 6. Bromopalmitate pretreatment inhibits surface expression of
the P2X7 receptor but does not abolish sensitivity to MCD. A and B, time
course of dye uptake by mouse P2X7 receptor (A) and human P2X7 receptor
(B) after 16 h of pretreatmentwith 100MBrP or DMSO (control). P2X7 recep-
tor-mediated dye uptake in BrP-treated cells was significantly potentiated by
5mMMCD (n 4 formouse, n 3 for human, p	 0.05). C, HeLa cells express-
ing mouse P2X7-FLAG receptors were immunostained by live labeling with
anti-FLAG antibody. BrP reduced the surface expression of mouse P2X7-
FLAG, but MCD treatment did not (scale bar  20 m, n  32–40 cells per
condition, **, p	 0.001; ns, not significant). D, Western blot of TSA 201 cells
expressing mouse P2X7 shows that pretreatment with BrP reduces total
expression of the receptor.
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Lys367). Whether or not this region is involved in the choles-
terol sensitivity of P2X1 remains to be established.
Although we favor the idea that cholesterol binds to P2X7 to
regulate its activity, an alternative possibility is that manipulat-
ing cholesterol levels changes the ordered structure and
arrangement of lipids around the receptor, thereby altering its
gating properties. For example, a reduction in cholesterol is
expected to increasemembrane fluidity, which could act to pro-
mote pore dilation, whereas increasing cholesterol and the
rigidity of the membrane would have the opposite effect (22).
The mutational analysis would then indicate that proximal
N- and C-terminal regions are important in coupling changes
in fluidity to the gating and dilation of the pore. The idea that
the gating of the P2X7 receptor channel is particularly sensitive
to the ordered nature of its lipid environment is supported by
previous studies that looked at the effect of lysolipid products of
phospholipase A2 on P2X7 receptor function and showed an
enhancement of function, whereas other P2X receptor sub-
types were relatively insensitive (54). Several lipids were exam-
ined, and those that enhanced receptor function were amphi-
philic and capable of integrating into lipid bilayers, thereby
disrupting its ordered structure and increasing fluidity. The
crystal structure of the P2X4 receptor in its ATP-bound open
state shows relatively few inter-subunit interactions in the
transmembrane domains, which is consistent with the idea that
the stability of this state, and evenmore so the dilated pore state
of P2X7, will be sensitive to the nature of the surrounding lipids
(55) (Protein Data Bank (PDB) number 4DW1).
In general, plasmamembrane cholesterol is tightly regulated
on a cellular level, through control of biosynthesis, efflux, and
FIGURE 7. The cysteine-rich regionwithin the proximal C terminus of P2X7 is important for normal pore dilation.A, time course of dye uptakemediated
by P2X718aa 5mMMCD normalized to the untreatedWT P2X7. B, relative rates of dye uptakemediated by P2X718aaMCD, normalized to untreated
WTP2X7 (WT: n 6 alone, n 2MCD;mutants: n 7 alone, n 4MCD; *, p	 0.05).C, Western blot shows that total (T) and surface-biotinylated (B) expression
of P2X718aa was similar to WT P2X7 (panel B). D, example whole-cell current recording for P2X718aa stimulated with repeated 5 s applications of 300M
BzATP. Currents had slow activation kinetics, exhibited run down, andwere flickery. E, themean peak current density for the first agonist application appeared
to be reduced byMCD treatment, although this was not significant (alone n 13, MCD n 8, p
 0.05). F, bar graph of the relative rates of dye uptake 5mM
MCD for P2X7 Cys to Ala mutants, normalized to untreatedWT P2X7. (WT: alone n 8, MCD n 11; Cys to Ala mutants: n 3–6; *, p	 0.05, **, p	 0.001; ns,
not significant). G, Western blot shows that surface expression of C363A and C373A mutants was similar to WT, whereas C371A and C377A mutants had
reduced surfaceexpression.H, whole-cell recordingof P2X7C363A receptor currents, stimulatedwith repeated5-s applicationsof 300MBzATP. I, P2X7C363A
mean peak current density upon first application of BzATP was potentiated by 5 mM MCD pretreatment (n 5, *, p	 0.05).
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influx. However, localized, acute changes in cholesterol are
likely to occur upon activation of signaling pathways linked to
lipid metabolism. Ceramide levels have been shown to increase
downstream of P2X7 receptor activation, via the action of sph-
ingomyelinases, and by de novo ceramide generation (16, 29,
30). Ceramide displaces cholesterol from rafts and increases
membrane fluidity (27, 56), which might contribute to stabili-
zation of the dilated state of the P2X7 receptor pore. This leads
to the hypothesis that perturbations in bilayer structure in the
immediate environment of the receptor contribute to its activ-
ity-dependent sensitization. In addition to acute changes in the
lipid environment of the receptor, longer-term changes might
occur as a consequence of dysregulation of the normal choles-
terol homeostatic mechanisms of the cell. For example, plasma
membrane cholesterol levels increase with aging, which corre-
lates with impairment in the innate immune response (57). In
intestinal epithelial cells, cholesterol accumulates in response
to exposure to Salmonella, leading to activation of anti-inflam-
matory pathways and protection of these cells from apoptosis
(58). Also in intestinal epithelial cells, lipid raft disruption was
shown to occur early in the inflammatory cascade in both
mouse and human colitis, leading to intestinal epithelial barrier
disruption (31). Given the role of P2X7 receptor in inflamma-
tion and apoptosis, it is tempting to speculate that dysregula-
tion of the P2X7 receptor as a result of disruption of cholesterol
homeostasis may play a role in some of these scenarios.
In conclusion, we have shown that changes in plasma mem-
brane cholesterol affect the activation and sensitization of the
P2X7 receptor; the rate of pore dilation is enhanced by deple-
tion of cholesterol and strongly suppressed by an increase in
cholesterol. This mode of regulation is particularly evident for
the human form of the receptor, which sensitizes more slowly
than the rodent isoforms. The targeting of P2X7 receptors to
cholesterol-rich lipid rafts is likely to be an important mode of
receptor regulation, whereas disruption of cholesterol homeo-
stasis may promote P2X7 receptor-mediated membrane per-
meabilization and subsequent cell death in disease states.
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